Dieser Artikel ist derzeit auf Englisch verfügbar.
AI Governance for Scale-Ups and Series A Companies: What Investors Are Now Asking, and How to Answer
Investors conducting due diligence on Series A and Series B companies are asking AI governance questions that founders are unprepared for. Here's what they're asking, why it matters for your valuation, and how to build the governance posture that answers confidently.
Key Takeaways
Series A and B investors with institutional LPs are incorporating AI governance into their investment due diligence — particularly for AI-native companies and companies in regulated sectors where AI governance failure creates material liability.
The four AI governance questions investors are asking: Do you have an AI system inventory? What is your training data provenance? Have you tested for bias in customer-facing AI? What would a regulatory enforcement action cost you?
Founders who cannot answer these questions specifically — not with talking points about responsible AI, but with documented evidence — are creating deal friction that affects valuation and terms.
AI governance is a competitive advantage in fundraising: founders who can demonstrate mature AI governance stand out in a market where most companies cannot — and sophisticated investors price this into deal terms.
The governance investment that moves the needle for investors is documentation, not policy — a well-documented AI system with clear risk assessment, bias testing results, and incident response procedures is worth more than a comprehensive AI ethics framework that has not been applied.
"Nur zu Informationszwecken. Dieser Artikel stellt keine rechtliche, regulatorische, finanzielle oder professionelle Beratung dar. Konsultieren Sie einen qualifizierten Spezialisten für spezifische Beratung."
Why AI governance became a Series A conversation
Two years ago, AI governance was rarely mentioned in Series A due diligence. Today it is a standard topic for any company with material AI in its product, and it is increasingly a negotiating point in term sheets. This shift happened for three reasons.
First, enforcement has arrived. The FTC's Operation AI Comply in September 2024 — five enforcement actions against companies making deceptive AI claims — sent a clear signal that AI-washing carries real legal consequences. The EEOC's 2023 guidance on AI in employment put employers on notice that discriminatory AI outcomes create federal liability. EU DPAs have been active against AI companies processing personal data without adequate safeguards. The legal risk of AI governance failure is no longer theoretical.
Second, enterprise customer due diligence has escalated. Large enterprise buyers — banks, healthcare companies, government agencies — are now running AI governance due diligence as part of their procurement process. If you want enterprise contracts, you need answers to questions about model validation, bias testing, data lineage, and incident response. A startup that cannot answer these questions gets disqualified at procurement, not at negotiation.
Third, institutional LPs are asking their GPs to demonstrate ESG and technology risk consideration. Governance and responsible AI have moved into the investment risk framework, and VCs need to be able to represent to their LPs that portfolio companies are not carrying undisclosed AI-related liability.
What investors are specifically asking
A Series A AI governance due diligence conversation typically covers five areas.
Data provenance and IP. What data was used to train the model? Do you have the legal right to use it for training? Were third-party datasets used, and if so, under what licence terms? Are there any open-source model components that carry licence restrictions (GPL, AGPL) that could affect your commercial product? Can you demonstrate clean data lineage from source to training corpus?
Output risk and liability. What is the highest-consequence decision your AI can influence? What happens when it is wrong? How is output quality monitored in production? What are the documented failure modes? Have you had any production incidents and if so, what happened?
Regulatory exposure. What regulations apply to your AI product by jurisdiction? Have you conducted a formal compliance assessment? Do you have legal counsel experienced in AI regulation? If you operate in the EU, have you assessed your product under the EU AI Act's risk classification? If you handle health data, are you complying with HIPAA (US), the Privacy Act (AU), or applicable health privacy regulations?
Customer contracts and liability. What do your customer agreements say about AI-generated outputs? Do you disclaim liability for AI errors, and is that disclaimer enforceable in the customer's jurisdiction? If your AI generates outputs that a customer relies on and those outputs are wrong, what is your exposure?
Governance structure. Who is responsible for AI governance at your company? Is there a documented AI policy? Have you adopted a recognised framework (NIST AI RMF, ISO 42001, AIRA)? Do you conduct regular bias testing and model monitoring? What is your incident response plan?
The most common governance gaps found in scale-up due diligence
Based on patterns in the market, the four issues most likely to surface in Series A AI governance reviews are:
Training data provenance. "We scraped it from the web" or "we bought a dataset" without documentation of licensing terms creates serious IP and regulatory risk. The litigation against OpenAI, Stability AI, and others over training data has raised investor awareness of this issue to the point where data lineage documentation is now expected.
No model versioning or logging. If you cannot answer "what version of the model made this decision and why?", you cannot conduct a meaningful incident investigation, demonstrate regulatory compliance, or support enterprise customer audits. Model versioning and decision logging are now baseline expectations.
Customer agreements that don't address AI. Standard SaaS agreements were not written for AI products. Terms around accuracy warranties, output liability, data use for model training, and change notifications all need AI-specific provisions. Enterprise customers are now refusing to sign agreements that don't address these.
No documented bias or fairness testing. If your AI makes decisions that affect people — credit, insurance, hiring, content moderation — you need documented evidence of fairness testing. "We tested it informally and it seemed fine" is not sufficient for enterprise buyers, regulators, or investors.
Preparing for a Series A governance conversation
Before your Series A process, compile a governance data room that includes: a brief AI system description covering what the model does, what data it processes, and what decisions it influences; a data provenance document covering your training data, its source, and your right to use it; your bias and fairness testing methodology and results; a summary of regulatory compliance assessment by jurisdiction; your incident history and response; and your standard customer agreement with the AI-related provisions highlighted. This document set signals governance maturity and pre-empts the most common diligence questions. Founders who show up with this prepared close faster and negotiate better.
The governance advantage
Governance is not just about risk mitigation. Scale-ups that have built governance infrastructure are better positioned to: win enterprise contracts that require it; expand into regulated sectors (financial services, healthcare, government); raise future rounds at better valuations; and defend against competitor challenges that governance failures cannot survive. The companies most disrupted by emerging AI regulation are the ones that assumed governance was someone else's problem. The ones best positioned are the ones that built it into their product architecture from early days.